KETOROLAC MEDSURGE ketorolac trometamol 10 mg/1 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ketorolac medsurge ketorolac trometamol 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - ketorolac trometamol, quantity: 10 mg - injection - excipient ingredients: sodium chloride; sodium hydroxide; water for injections; hydrochloric acid; ethanol - ketorolac medsurge solution for injection is indicated for the short-term management of moderately severe, acute pain following surgical procedures. the total duration of ketorolac use should not exceed five days. it is recommended that ketorolac parenteral be used in the immediate post-operative period. patients can then be converted to the oral formulation (dependent on their analgesic needs), as outlined in the section 4.2 dose and method of administration (refer to conversion from parenteral to oral therapy). the total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days. note that oral dosage forms are available from other brands.,general,ketorolac medsurge solution for injection is not recommended for use as an obstetrical pre-operative medication or for obstetrical analgesia because it has not been adequately studied for use in these circumstances and because the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and foetal circulation.,there is no satisfactory evidence for the use of ketorolac medsurge solution for injection in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid or osteoarthritis).

KETOROLAC MEDSURGE ketorolac trometamol 30 mg/1 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ketorolac medsurge ketorolac trometamol 30 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - ketorolac trometamol, quantity: 30 mg - injection - excipient ingredients: sodium chloride; ethanol; sodium hydroxide; hydrochloric acid; water for injections - ketorolac medsurge solution for injection is indicated for the short-term management of moderately severe, acute pain following surgical procedures. the total duration of ketorolac use should not exceed five days. it is recommended that ketorolac parenteral be used in the immediate post-operative period. patients can then be converted to the oral formulation (dependent on their analgesic needs), as outlined in the section 4.2 dose and method of administration (refer to conversion from parenteral to oral therapy). the total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days. note that oral dosage forms are available from other brands.,general,ketorolac medsurge solution for injection is not recommended for use as an obstetrical pre-operative medication or for obstetrical analgesia because it has not been adequately studied for use in these circumstances and because the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and foetal circulation.,there is no satisfactory evidence for the use of ketorolac medsurge solution for injection in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid or osteoarthritis).

Mepiblock 20 mg/ml solution for injection for horses Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

mepiblock 20 mg/ml solution for injection for horses

dechra ltd - mepivacaine hydrochloride - solution for injection - 20 milligram(s)/millilitre - mepivacaine - horses - anaesthetic/analgesic

OXYCODONE HCl 10 mg/1 mL MEDSURGE oxycodone hydrochloride 10 mg/1 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 10 mg/1 ml medsurge oxycodone hydrochloride 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; hydrochloric acid; citric acid monohydrate; sodium chloride; sodium hydroxide; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 20 mg/2 mL MEDSURGE oxycodone hydrochloride 20 mg/2 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 20 mg/2 ml medsurge oxycodone hydrochloride 20 mg/2 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid; sodium citrate dihydrate - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYCODONE HCl 50 mg/1 mL MEDSURGE oxycodone hydrochloride 50 mg/1 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYNORM oxycodone hydrochloride 20mg in 2mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

oxynorm oxycodone hydrochloride 20mg in 2ml solution for injection ampoule

mundipharma pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; citric acid monohydrate; hydrochloric acid; sodium chloride; sodium citrate dihydrate; water for injections - oxynorm solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

OXYNORM oxycodone hydrochloride 10mg in 1mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

oxynorm oxycodone hydrochloride 10mg in 1ml solution for injection ampoule

mundipharma pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium chloride; sodium hydroxide; citric acid monohydrate; water for injections; hydrochloric acid - oxynorm solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

DROPERIDOL 2.5 mg/1 mL MEDSURGE droperidol 2.5 mg/1 mL solution for injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

droperidol 2.5 mg/1 ml medsurge droperidol 2.5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - droperidol, quantity: 2.5 mg/ml - injection, solution - excipient ingredients: tartaric acid; water for injections; sodium hydroxide; mannitol - anaesthesia droperidol solution for injection is indicated to produce tranquillisation and to reduce the incidence of nausea and vomiting in surgical and diagnostic procedures; for premedication, induction, and as an adjunct in the maintenance of general and regional anaesthesia; in neuroleptanalgesia in which droperidol solution for injection is given concurrently with a narcotic analgesic, to aid in producing tranquillity and decreasing anxiety and pain.,psychiatry the management of severe agitation, hyperactivity, or aggressiveness in psychotic disorders, including schizophrenic reaction and the manic type of manic depressive illness, or in disturbed states, such as some types of acute brain syndrome and in nonpsychotic acute excitation states.

Bupivacaine 50mg/10ml (0.5%) solution for injection ampoules Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

bupivacaine 50mg/10ml (0.5%) solution for injection ampoules

0.5%) solution for injection ampoules (accord-uk ltd - bupivacaine hydrochloride - solution for injection - 5mg/1ml